Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Litecoin (LTC) Price & Performance

InjectiveTrade
LitecoinTrade

Price performance (Past 24H)

Key statistics

Injective vs Litecoin — how do they compare? Injective trades at Rp92,485 (market cap Rp9,38T, Rp1,76T 24h volume), while Litecoin trades at Rp814,870 (market cap Rp63,86T, Rp5,66T 24h volume). The key difference: Litecoin is far larger — about 6.8× Injective's market cap, and Litecoin's supply is capped (77,4M / 84M LTC (93%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Litecoin for 75 Days on average.

INJLTC
Market Cap
Rp9,38TRp63,86T
Volume (24h)
Rp1,76TRp5,66T
Circulating Supply
100M INJ77,4M / 84M LTC (93%)
Typical Hold Time
36 Days75 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Litecoin

Litecoin (LTC) is trading at Rp814,166 with a market cap of Rp63.19 trillion, showing a bullish technical signal with strong moving averages but neutral oscillators. The current price sits above the pivot point of Rp810,477, indicating positive momentum, though RSI_6 at 72.27 suggests potential overbought conditions. On-chain metrics show 93% of max supply in circulation with an average hold time of 75 days, reflecting steady network participation.

Overall outlook is cautiously optimistic due to technical strength and established market position, but investors should monitor overbought signals and regulatory developments. Key opportunities include Litecoin's liquidity and adoption as a payment token, while risks involve crypto market volatility and competition from newer layer-1 solutions.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
LTC
87% Buy13% Sell
Avg holding period · 75 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Litecoin

Litecoin was launched in late 2011 by former Google and Coinbase engineer, Charlie Lee. It was designed to provide fast, secure and low-cost payments by leveraging the unique properties of blockchain technology. It also has a maximum supply of 84 million litecoins.

Read more on LTC